1. Editorial

   • Trevor W. Robbins
   • David J. Nutt
   • Harriet de Wit

   Editorial 01 July 2005 Pages: 581 - 582

2. Neurocircuitry in alcoholism: a substrate of disruption and repair

   • Edith V. Sullivan
   • Adolf Pfefferbaum

   Review 15 April 2005 Pages: 583 - 594

   

3. GABA-benzodiazepine receptor function in alcohol dependence: a combined ¹¹C-flumazenil PET and pharmacodynamic study

   • A. R. Lingford-Hughes
   • S. J. Wilson
   • D. J. Nutt

   Original Investigation 28 April 2005 Pages: 595 - 606

   

4. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users

   • Jörg Daumann
   • Thomas Fischermann
   • Euphrosyne Gouzoulis-Mayfrank

   Original Investigation 15 September 2004 Pages: 607 - 611

   

5. Abnormal frontal activations related to decision-making in current and former amphetamine and opiate dependent individuals

   • K. D. Ersche
   • P. C. Fletcher
   • B. J. Sahakian

   Original Investigation 15 March 2005 Pages: 612 - 623

   

6. Plasma level-dependent effects of methylphenidate on task-related functional magnetic resonance imaging signal changes

   • Ulrich Müller
   • J. Suckling
   • E. T. Bullmore

   Original Investigation 14 April 2005 Pages: 624 - 633

   

7. Processing efficiency of a verbal working memory system is modulated by amphetamine: an fMRI investigation

   • Christine M. Tipper
   • Tara A. Cairo
   • Elton T. C. Ngan

   Original Investigation 28 June 2005 Pages: 634 - 643

   

8. A functional MRI study of the effects of bromocriptine, a dopamine receptor agonist, on component processes of working memory

   • Sasha E. B. Gibbs
   • Mark D'Esposito

   Original Investigation 07 July 2005 Pages: 1 - 10

   

9. The effects of acute tyrosine and phenylalanine depletion on spatial working memory and planning in healthy volunteers are predicted by changes in striatal dopamine levels

   • Mitul A. Mehta
   • Deepa Gumaste
   • Paul M. Grasby

   Original Investigation 26 January 2005 Pages: 654 - 663

   

10. Non-uniform blockade of intrastriatal D₂/D₃ receptors by risperidone and amisulpride

    • James M. Stone
    • Rodrigo A. Bressan
    • Lyn S. Pilowsky

    Original Investigation 18 February 2005 Pages: 664 - 669

    

11. Individual differences in threat sensitivity predict serotonergic modulation of amygdala response to fearful faces

    • Roshan Cools
    • Andy J. Calder
    • Trevor W. Robbins

    Original Investigation 17 March 2005 Pages: 670 - 679

    

12. Neuronal effects of acute citalopram detected by pharmacoMRI

    • S. McKie
    • C. Del-Ben
    • J. F. W. Deakin

    Original Investigation 12 May 2005 Pages: 680 - 686

    

13. Methodological considerations in rat brain BOLD contrast pharmacological MRI

    • C. A. Steward
    • C. A. Marsden
    • Y. B. Shah

    Review 19 March 2005 Pages: 687 - 704

    

14. Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging

    • Yin-Ching I. Chen
    • Ji-Kyung Choi
    • Bruce G. Jenkins

    Original Investigation 05 November 2004 Pages: 705 - 715

    

15. Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder

    • Katherine N. Hewitt
    • Yasmene B. Shah
    • Charles A. Marsden

    Original Investigation 28 April 2005 Pages: 716 - 723

    

16. Functional magnetic resonance imaging reveals similar brain activity changes in two different animal models of schizophrenia

    • Céline Risterucci
    • Karine Jeanneau
    • Jean-Luc Moreau

    Original Investigation 22 February 2005 Pages: 724 - 734

    

17. D₂ but not D₁ dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats

    • Abesh Kumar Bhattacharjee
    • Lisa Chang
    • Stanley I. Rapoport

    Original Investigation 15 March 2005 Pages: 735 - 742

    

18. Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging

    • Nicholas Jones
    • Michael J. O’Neill
    • Steve C. R. Williams

    Original Investigation 28 April 2005 Pages: 743 - 751

    

19. Effect of Thunbergia laurifolia, a Thai natural product used to treat drug addiction, on cerebral activity detected by functional magnetic resonance imaging in the rat

    • Watchareewan Thongsaard
    • Charles A. Marsden
    • Yasmene B. Shah

    Original Investigation 02 July 2005 Pages: 1 - 9

    

20. Functional magnetic resonance imaging studies of opioid receptor-mediated modulation of noxious-evoked BOLD contrast in rats

    • Y. B. Shah
    • L. Haynes
    • V. Chapman

    Original Investigation 19 March 2005 Pages: 761 - 773

    

21. The phenylephrine blood pressure clamp in pharmacologic magnetic resonance imaging: reduction of systemic confounds and improved detectability of drug-induced BOLD signal changes

    • Raffael Kalisch
    • Marina Delfino
    • Dorothee P. Auer

    Original Investigation 28 April 2005 Pages: 774 - 780

    

22. Effects of chronic cocaine self-administration on norepinephrine transporters in the nonhuman primate brain

    • Thomas J. R. Beveridge
    • Hilary R. Smith
    • Linda J. Porrino

    Original Investigation 01 March 2005 Pages: 781 - 788

    

23. A proof-of-concept study using [¹¹C]flumazenil PET to demonstrate that pagoclone is a partial agonist

    • A. Lingford-Hughes
    • S. J. Wilson
    • D. J. Nutt

    Letter to the Editors 29 June 2005 Pages: 1 - 3